Chemotherapy for melanoma: the resultant of conflicting vectors.
Mitchell
Malcolm S
MS
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D045744:Cell Line, Tumor; D003606:Dacarbazine / Q000009:adverse effects*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine